Cargando…

Quantitative SPECT/CT imaging of lead-212: a phantom study

BACKGROUND: Lead-212 ((212)Pb) is a promising radionuclide for targeted therapy, as it decays to α-particle emitter bismuth-212 ((212)Bi) via β-particle emission. This extends the problematic short half-life of (212)Bi. In preparation for upcoming clinical trials with (212)Pb, the feasibility of qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvassheim, Monika, Revheim, Mona-Elisabeth R., Stokke, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352840/
https://www.ncbi.nlm.nih.gov/pubmed/35925521
http://dx.doi.org/10.1186/s40658-022-00481-z
_version_ 1784762737318952960
author Kvassheim, Monika
Revheim, Mona-Elisabeth R.
Stokke, Caroline
author_facet Kvassheim, Monika
Revheim, Mona-Elisabeth R.
Stokke, Caroline
author_sort Kvassheim, Monika
collection PubMed
description BACKGROUND: Lead-212 ((212)Pb) is a promising radionuclide for targeted therapy, as it decays to α-particle emitter bismuth-212 ((212)Bi) via β-particle emission. This extends the problematic short half-life of (212)Bi. In preparation for upcoming clinical trials with (212)Pb, the feasibility of quantitative single photon-emission computed tomography/computed tomography (SPECT/CT) imaging of (212)Pb was studied, with the purpose to explore the possibility of individualised patient dosimetric estimation. RESULTS: Both acquisition parameters (combining two different energy windows and two different collimators) and iterative reconstruction parameters (varying the iterations x subsets between 10 × 1, 15 × 1, 30 × 1, 30 × 2, 30 × 3, 30 × 4, and 30 × 30) were investigated to evaluate visual quality and quantitative uncertainties based on phantom images. Calibration factors were determined using a homogeneous phantom and were stable when the total activity imaged exceeded 1 MBq for all the imaging protocols studied, but they increased sharply as the activity decayed below 1 MBq. Both a 20% window centred on 239 keV and a 40% window on 79 keV, with dual scatter windows of 5% and 20%, respectively, could be used. Visual quality at the lowest activity concentrations was improved with the High Energy collimator and the 79 keV energy window. Fractional uncertainty in the activity quantitation, including uncertainties from calibration factors and small volume effects, in spheres of 2.6 ml in the NEMA phantom was 16–21% for all protocols with the 30 × 4 filtered reconstruction except the High Energy collimator with the 239 keV energy window. Quantitative analysis was possible both with and without filters, but the visual quality of the images improved with a filter. CONCLUSIONS: Only minor differences were observed between the imaging protocols which were all determined suitable for quantitative imaging of (212)Pb. As uncertainties generally decreased with increasing iterative updates in the reconstruction and recovery curves did not converge with few iterations, a high number of reconstruction updates are recommended for quantitative imaging. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40658-022-00481-z.
format Online
Article
Text
id pubmed-9352840
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93528402022-08-06 Quantitative SPECT/CT imaging of lead-212: a phantom study Kvassheim, Monika Revheim, Mona-Elisabeth R. Stokke, Caroline EJNMMI Phys Original Research BACKGROUND: Lead-212 ((212)Pb) is a promising radionuclide for targeted therapy, as it decays to α-particle emitter bismuth-212 ((212)Bi) via β-particle emission. This extends the problematic short half-life of (212)Bi. In preparation for upcoming clinical trials with (212)Pb, the feasibility of quantitative single photon-emission computed tomography/computed tomography (SPECT/CT) imaging of (212)Pb was studied, with the purpose to explore the possibility of individualised patient dosimetric estimation. RESULTS: Both acquisition parameters (combining two different energy windows and two different collimators) and iterative reconstruction parameters (varying the iterations x subsets between 10 × 1, 15 × 1, 30 × 1, 30 × 2, 30 × 3, 30 × 4, and 30 × 30) were investigated to evaluate visual quality and quantitative uncertainties based on phantom images. Calibration factors were determined using a homogeneous phantom and were stable when the total activity imaged exceeded 1 MBq for all the imaging protocols studied, but they increased sharply as the activity decayed below 1 MBq. Both a 20% window centred on 239 keV and a 40% window on 79 keV, with dual scatter windows of 5% and 20%, respectively, could be used. Visual quality at the lowest activity concentrations was improved with the High Energy collimator and the 79 keV energy window. Fractional uncertainty in the activity quantitation, including uncertainties from calibration factors and small volume effects, in spheres of 2.6 ml in the NEMA phantom was 16–21% for all protocols with the 30 × 4 filtered reconstruction except the High Energy collimator with the 239 keV energy window. Quantitative analysis was possible both with and without filters, but the visual quality of the images improved with a filter. CONCLUSIONS: Only minor differences were observed between the imaging protocols which were all determined suitable for quantitative imaging of (212)Pb. As uncertainties generally decreased with increasing iterative updates in the reconstruction and recovery curves did not converge with few iterations, a high number of reconstruction updates are recommended for quantitative imaging. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40658-022-00481-z. Springer International Publishing 2022-08-04 /pmc/articles/PMC9352840/ /pubmed/35925521 http://dx.doi.org/10.1186/s40658-022-00481-z Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Kvassheim, Monika
Revheim, Mona-Elisabeth R.
Stokke, Caroline
Quantitative SPECT/CT imaging of lead-212: a phantom study
title Quantitative SPECT/CT imaging of lead-212: a phantom study
title_full Quantitative SPECT/CT imaging of lead-212: a phantom study
title_fullStr Quantitative SPECT/CT imaging of lead-212: a phantom study
title_full_unstemmed Quantitative SPECT/CT imaging of lead-212: a phantom study
title_short Quantitative SPECT/CT imaging of lead-212: a phantom study
title_sort quantitative spect/ct imaging of lead-212: a phantom study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352840/
https://www.ncbi.nlm.nih.gov/pubmed/35925521
http://dx.doi.org/10.1186/s40658-022-00481-z
work_keys_str_mv AT kvassheimmonika quantitativespectctimagingoflead212aphantomstudy
AT revheimmonaelisabethr quantitativespectctimagingoflead212aphantomstudy
AT stokkecaroline quantitativespectctimagingoflead212aphantomstudy